ALNYLAM PHARMACEUTICALS, INC. Annual Return On Assets in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2011 to 2023.
  • Alnylam Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -1.88 %, a 93.9% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2023 was -12.2 %, a 62.7% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2022 was -32.7 %, a 33% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2021 was -24.6 %, a 11.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -12.2 +20.5 +62.7% Jan 1, 2023 Dec 31, 2023
2022 -32.7 -8.1 -33% Jan 1, 2022 Dec 31, 2022
2021 -24.6 +3.18 +11.5% Jan 1, 2021 Dec 31, 2021
2020 -27.8 +8.91 +24.3% Jan 1, 2020 Dec 31, 2020
2019 -36.7 +7.08 +16.2% Jan 1, 2019 Dec 31, 2019
2018 -43.8 -10.6 -31.9% Jan 1, 2018 Dec 31, 2018
2017 -33.2 -2.06 -6.62% Jan 1, 2017 Dec 31, 2017
2016 -31.1 -11.7 -60.3% Jan 1, 2016 Dec 31, 2016
2015 -19.4 +15.1 +43.8% Jan 1, 2015 Dec 31, 2015
2014 -34.5 -14.7 -74.2% Jan 1, 2014 Dec 31, 2014
2013 -19.8 +13.6 +40.7% Jan 1, 2013 Dec 31, 2013
2012 -33.4 -15.7 -88.8% Jan 1, 2012 Dec 31, 2012
2011 -17.7 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.